Effect of glecaprevir/pibrentasvir on weight‐adjusted tacrolimus trough/dose ratios in heart and kidney transplant recipients-Reference-Cited by-同舟云学术

Effect of glecaprevir/pibrentasvir on weight‐adjusted tacrolimus trough/dose ratios in heart and kidney transplant recipients

Published:2021-08-27 Issue:5 Volume:23 Page:
ISSN:1398-2273
Container-title:Transplant Infectious Disease
language:en
Short-container-title:Transpl Infect Dis

Author:

Nnani Daryl U.¹^ORCID,Campbell Alesa¹^ORCID,Ajaimy Maria²^ORCID,Saeed Omar³^ORCID,Patel Snehal R.³^ORCID,Ahmed Sana¹,Graham Jay A.⁴^ORCID,Jorde Ulrich P.³^ORCID

Affiliation:

1. Department of Pharmacy Montefiore Medical Center Bronx New York USA

2. Department of Medicine Montefiore Medical Center Bronx New York USA

3. Division of Cardiology Montefiore Medical Center Bronx New York USA

4. Department of Surgery Montefiore Medical Center Bronx New York USA

Publisher

Wiley

Subject

Infectious Diseases,Transplantation

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/tid.13716

Reference25 articles.

1. Increasing access to thoracic organs from donors infected with hepatitis C: A previous challenge—now an opportunity

2. Transplanting Hepatitis C–Positive Kidneys

3. Transplantation of viral‐positive hepatitis C‐positive kidneys into uninfected recipients offers an opportunity to increase organ access

4. Direct-acting antiviral treatment for hepatitis C

5. Commercial insurance delays direct‐acting antiviral treatment for hepatitis C kidney transplantation into uninfected recipients

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evolution of heart transplant donor characteristics in the 21^st century: A United States single center’s experience;World Journal of Transplantation;2024-09-18

2. Real‐world experience in treatment of donor‐derived Hepatitis C virus in kidney transplant recipients with delayed initiation, shortened course glecaprevir/pibrentasvir versus standard of care;Transplant Infectious Disease;2024-09-03

3. Hepatitis C and heart transplantation: An update;Clinical Transplantation;2023-08-31

4. Kidney transplant from HCV viremic donors to HCV‐negative recipients and risk for de novo donor specific antibodies and acute rejection;Clinical Transplantation;2023-01-11